Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 | Mind Blowing Facts

Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy.

Benzinga

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30.

Benzinga

Chic, ultra-curated and small-batch: how second-hand fashion is moving on from Vinted

Style-conscious shoppers are increasingly turning to small-batch fashion sites to curate their look for them. As second-hand September kicks off, we meet the people making it happen

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Teva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish Traders

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

Barchart

While you may be attached to strappy sandals – here are some trending options that won’t leave you with blisters.

The Independent UK

Victoria Beckham swears by this flattering jeans shape, and her tomato red polo top makes them feel so fresh for 2025

She was pictured in Paris, wearing the denim style she's championed for over a decade

Woman & Home

It's true: it doesn't get any chicer than Demi Moore's white turn-up jeans and comfy Teva sandals

We've found similar Tevas for under £30

Woman & Home

Read news from The Economist, FT, and more,
with one subscription

According to Mary-Kate Olsen, these Affordable Sandals are the Only Style you Need this Summer

And no, they're not from The Row

Marie Claire

Sandals on the trail: smart swap or risky move?

Hiking sandals are making a comeback as an outdoor staple, but are they really adventure-ready?

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

The Guardian - UK

These Are the 2 Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

This article highlights the two worst-performing S&P 500 stocks in 2025 and discusses whether they present a buying opportunity.

Barchart

Can't wait for Hoka's adventure sandal to be released? Teva's new technical Grandview Max has arrived, and it's ready to tackle the trails

Teva has been crafting technical sandals for over 40 years

Advnture

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

MarketBeat

2 Generic Drug Stocks Ready to Surge in 2025

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Woman & Home

Teva Grandview GORE-TEX review: 'Triumphant' on tricky trails with supreme support and unbeatable waterproofing

The Teva Grandview GORE-TEX is an all-rounder for winter weather. Here, hiker Susan Griffin reveals why it's a must-buy this year

Top News

EU Fines Teva 0M For Misusing Patent Protection

European Commission fines Teva over 460 million euros for improper practices related to Copaxone drug and disparagement of competitor.

The Independent UK

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing medicine

The Guardian - UK

Post-budget sell-off of government bonds by worried City traders intensifies, pushing up UK borrowing costs – as it happened

Institute for Fiscal Studies says increasing borrowing to fund investment ‘right thing to do’

Get all your
news in one place.

100's of premium titles.
One news app.

Woman & Home

Hoka Speedgoat 6 review: These comfortable walking shoes gave me my confidence back on the trails

If you like to walk and run for exercise, the Hoka Speedgoat 6 could be for you. Writer Susan Griffin reveals why you should give these colourful trainers a chance

Woman & Home

Ariat Skyline Summit Low Waterproof Boot review: After years of searching for my favourite walking shoe, I've gone back to basics

Hiker Susan Griffin took these Ariat walking shoes for a spin around boggy marshes and uneven trails. Here's how it went - and the winning feature that makes them her favourite

Woman & Home

We rated these Amazon walking shoes almost 5-stars in our review - and they are just £50 right now

The Jack Walker Lily Outdoor Shoes may not score top marks in the looks department but they are a winner in every other way. Here, Susan Griffin reviews

The Conversation

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

Woman & Home

Teva Trailwinder Low review: Finally, a comfortable pair of walking shoes I can wear every day

Teva walking shoes are some of my favourites, says hiker Susan Griffin, but the Teva Trailwinder Low takes the top spot for comfort and style - here's why.

Marie Claire

Malia Obama Brunches With a Brat Green Octopus Purse and Polarizing Sporty Sandals

The former first daughter's outfit caused quite a stir.

International Business Times

New Generic Diabetes Drug Shows How Medical Innovation Works

The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug.

1 2 3 4 5

People

Deborah SheridanTaylor

18 stories

Lady Victoria

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.